|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
TALQUETAMAB |
L01FX29 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE |
R03AL11 |
RO
|
POM
|
20-11-2023 |
EMEA/H/C/004983 |
09-12-2020 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
RO
|
Not authorised
|
20-11-2023 |
|
|
VALID
|
|
FERRIC MALTOL |
B03AB10 |
RO
|
Not authorised
|
21-11-2023 |
|
|
VALID
|
|
IRON, VITAMIN B12 AND FOLIC ACID |
B03AE01 |
RO
|
Not authorised
|
21-11-2023 |
|
|
VALID
|
|
IVACAFTOR AND TEZACAFTOR |
R07AX31 |
RO
|
POM
|
21-11-2023 |
EMEA/H/C/004682 |
31-10-2018 |
VALID
|
|
SACCHARATED IRON OXIDE |
B03AB02 |
RO
|
Not authorised
|
21-11-2023 |
|
|
VALID
|
|
VOCLOSPORIN |
L04AD03 |
RO
|
POM
|
21-11-2023 |
EMEA/H/C/005256 |
15-09-2022 |
VALID
|
|
DARVADSTROCEL |
L04AX08 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/004258 |
23-03-2018 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
LUMASIRAN |
A16AX18 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005040 |
19-11-2020 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
RELUGOLIX |
L02BX04 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
RELUGOLIX, ESTRADIOL AND NORETHISTERONE |
H01CC54 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005267 |
16-07-2021 |
VALID
|
|
ROMOSOZUMAB |
M05BX06 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/004465 |
09-12-2019 |
VALID
|
|
VUTRISIRAN |
N07XX18 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005852 |
15-09-2022 |
VALID
|
|
ZANUBRUTINIB |
L01EL03 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/004978 |
22-11-2021 |
VALID
|
|
MACROGOL |
A06AD15 |
RO
|
Not subject to prescription
|
07-02-2024 |
5685 |
|
VALID
|
|
PRAVASTATIN AND FENOFIBRATE |
C10BA03 |
RO
|
Not authorised
|
07-02-2024 |
|
|
VALID
|
|
SIMVASTATIN AND FENOFIBRATE |
C10BA04 |
RO
|
Not authorised
|
07-02-2024 |
|
|
VALID
|
|
CONJUGATED ESTROGENS AND BAZEDOXIFENE |
G03CC07 |
RO
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
NORETHISTERONE AND ESTROGEN |
G03FB05 |
RO
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
PREDNISOLONE |
H02AB06 |
RO
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
PROMESTRIENE |
G03CA09 |
RO
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
CYPROTERONE |
G03HA01 |
RO
|
List I
|
22-02-2024 |
|
|
VALID
|
|
ESTRADIOL |
G03CA03 |
RO
|
List II
|
22-02-2024 |
|
|
VALID
|
|
TERLIPRESSIN |
H01BA04 |
RO
|
List I
|
22-02-2024 |
|
|
VALID
|
|
TIBOLONE |
G03CX01 |
RO
|
List I
|
22-02-2024 |
|
|
VALID
|
|
NICOTINIC ACID, COMBINATIONS |
C10AD52 |
RO
|
Not authorised
|
18-04-2024 |
|
|
VALID
|
|
ADAGRASIB |
L01XX77 |
RO
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
RO
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
ELRANATAMAB |
L01FX32 |
RO
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
ETRASIMOD |
L04AE05 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
RO
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
FEZOLINETANT |
G02CX06 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
VAMOROLONE |
H02AB18 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|